Utama › Penyakit Crohn
Kajian klinikal Penyakit Crohn sedang mengambil peserta di AS
93 kajian untuk Penyakit Crohn sedang mengambil peserta di lokasi seluruh Amerika Syarikat.
Bandar dengan paling banyak kajian
- New York City, NY35 kajian
- St. Louis, MO19 kajian
- Cleveland, OH19 kajian
- Boston, MA19 kajian
- Miami, FL19 kajian
- Orlando, FL17 kajian
- Houston, TX17 kajian
- Atlanta, GA17 kajian
- Tyler, TX16 kajian
- San Diego, CA15 kajian
- San Antonio, TX15 kajian
- Los Angeles, CA15 kajian
- Philadelphia, PA13 kajian
- Colorado Springs, CO13 kajian
- Durham, NC12 kajian
- Providence, RI12 kajian
- Tacoma, WA11 kajian
- Pittsburgh, PA11 kajian
- Cincinnati, OH11 kajian
- Seattle, WA11 kajian
- Baltimore, MD10 kajian
- Washington, DC10 kajian
- Indianapolis, IN10 kajian
- Dallas, TX10 kajian
- Tampa, FL10 kajian
- Lubbock, TX10 kajian
- Ann Arbor, MI9 kajian
- Chicago, IL9 kajian
- Louisville, KY9 kajian
- Lewisville, TX9 kajian
- Evanston, IL9 kajian
- Rochester, MN8 kajian
- Parma, OH8 kajian
- New Haven, CT8 kajian
- Columbus, OH8 kajian
- Charlotte, NC8 kajian
- Independence, MO8 kajian
- Lafayette, LA7 kajian
- Milwaukee, WI7 kajian
- Queens, NY7 kajian
Mengikut negeri
- Alabama9 kajian
- Arizona17 kajian
- Arkansas3 kajian
- California37 kajian
- Colorado18 kajian
- Connecticut14 kajian
- Florida27 kajian
- Georgia22 kajian
- Idaho4 kajian
- Illinois18 kajian
- Indiana13 kajian
- Iowa8 kajian
- Kansas11 kajian
- Kentucky12 kajian
- Louisiana11 kajian
- Maryland15 kajian
- Massachusetts27 kajian
- Michigan20 kajian
- Minnesota11 kajian
- Mississippi3 kajian
- Missouri21 kajian
- Nevada8 kajian
- New Hampshire3 kajian
- New Jersey9 kajian
- New York36 kajian
- North Carolina20 kajian
- Ohio30 kajian
- Oklahoma8 kajian
- Oregon4 kajian
- Pennsylvania23 kajian
- Rhode Island12 kajian
- South Carolina11 kajian
- South Dakota4 kajian
- Tennessee10 kajian
- Texas35 kajian
- Utah8 kajian
- Virginia15 kajian
- Washington22 kajian
- Wilayah Columbia4 kajian
- Wisconsin7 kajian
Kajian yang dikemas kini baru-baru ini
Teks kajian rasmi (Bahasa Inggeris)
Longitudinal Immunophenotyping of Patients With Inflammatory Bowel Disease
Mengambil pesertaKajian pemerhatian
Umur 18 hingga 85 · Semua jantina · Dikemas kini 2 Okt 2026 · NCT07619547Extension Study of Long-term Safety and Efficacy of Tulisokibart in Participants With Crohn's Disease or Ulcerative Colitis (MK-7240-011)
Mengambil pesertaFasa 3
Semua umur · Semua jantina · Dikemas kini 2 Okt 2026 · NCT06651281A Study to Evaluate the Efficacy and Safety of Tulisokibart (MK-7240) in Participants With Moderate to Severe Crohn's Disease (MK-7240-008)
Mengambil pesertaFasa 3
Umur 16 hingga 80 · Semua jantina · Dikemas kini 2 Okt 2026 · NCT06430801Study of Advanced Therapies for the Treatment of Adult Participants With Moderately to Severely Active Crohn's Disease or Ulcerative Colitis
Mengambil pesertaFasa 2
Umur 18 hingga 75 · Semua jantina · Dikemas kini 2 Okt 2026 · NCT07697456Feasibility of a Wireless Thermal Capsule Endoscopy to Detect Gastrointestinal Thermal Variance
Mengambil pesertaSukarelawan sihat dialu-alukan
Umur 18 hingga 75 · Semua jantina · Dikemas kini 2 Okt 2026 · NCT07033208Investigating the Effect of the Non-nutritive Sweetener Sucralose in Inflammatory Bowel Disease
Mengambil pesertaSukarelawan sihat dialu-alukan
Umur 18 hingga 75 · Semua jantina · Dikemas kini 1 Okt 2026 · NCT07852273A Study of Vedolizumab in Adults With Ulcerative Colitis (UC) or Crohn's Disease (CD) in the Community Setting
Mengambil pesertaFasa 4
Umur 18 hingga 80 · Semua jantina · Dikemas kini 30 Sep 2026 · NCT06581328Non-nutritive Sweeteners in Inflammatory Bowel Disease
Mengambil pesertaSukarelawan sihat dialu-alukan
Umur 18 hingga 70 · Semua jantina · Dikemas kini 25 Sep 2026 · NCT07769437A Study of Guselkumab in Pediatric Participants With Moderately to Severely Active Crohn's Disease
Mengambil pesertaFasa 3
Umur 2 hingga 17 · Semua jantina · Dikemas kini 25 Sep 2026 · NCT05923073Study of Targeted Therapies for the Treatment of Adult Participants With Moderate to Severe Crohn's Disease
Mengambil pesertaFasa 2
Umur 18 hingga 75 · Semua jantina · Dikemas kini 25 Sep 2026 · NCT06548542A Study of Guselkumab Versus Risankizumab in Participants With Moderately to Severely Active Crohn's Disease
Mengambil pesertaFasa 3
Umur 18 ke atas · Semua jantina · Dikemas kini 25 Sep 2026 · NCT07499232A Study of Icotrokinra in Participants With Moderately to Severely Active Crohn's Disease
Mengambil pesertaFasa 2/3
Umur 18 ke atas · Semua jantina · Dikemas kini 25 Sep 2026 · NCT07196722A Long-term Extension (LTE) Study of Guselkumab in Pediatric Participants
Mengambil pesertaFasa 3
Umur 3 ke atas · Semua jantina · Dikemas kini 25 Sep 2026 · NCT06663332A Study on the Safety of TAK-279 and Whether it Can Reduce Inflammation in the Bowel of Participants With Moderately to Severely Active Crohn's Disease
Mengambil pesertaFasa 2
Umur 18 hingga 75 · Semua jantina · Dikemas kini 25 Sep 2026 · NCT06233461Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight
Mengambil pesertaFasa 3
Umur 18 hingga 70 · Semua jantina · Dikemas kini 24 Sep 2026 · NCT06937099Tailored Anti-Inflammatory American Diet for Patients With Crohn's Disease
Mengambil peserta
Umur 16 hingga 75 · Semua jantina · Dikemas kini 24 Sep 2026 · NCT07671872Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO
Mengambil pesertaFasa 1
Umur 18 ke atas · Semua jantina · Dikemas kini 23 Sep 2026 · NCT03816345An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Crohn's Disease
Mengambil pesertaFasa 3
Umur 16 hingga 80 · Semua jantina · Dikemas kini 23 Sep 2026 · NCT07184931A Maintenance Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Crohn's Disease
Mengambil pesertaFasa 3
Umur 16 hingga 80 · Semua jantina · Dikemas kini 23 Sep 2026 · NCT07184944A Study to Assess Adverse Events, Change in Disease Activity, and How Intravenous and Subcutaneous Risankizumab Moves Through the Body of Pediatric Participants With Moderately to Severely Active Crohn's Disease
Mengambil pesertaFasa 3
Umur 2 hingga 17 · Semua jantina · Dikemas kini 23 Sep 2026 · NCT05995353A Phase 2 Study to Evaluate MORF-057 in Adults With Moderately to Severely Active Crohn's Disease
Mengambil pesertaFasa 2
Umur 18 hingga 85 · Semua jantina · Dikemas kini 22 Sep 2026 · NCT06226883A Master Protocol (IIBD): A Study of Multiple Drugs in Adults With Ulcerative Colitis or Crohn's Disease
Mengambil pesertaFasa 2
Umur 18 hingga 80 · Semua jantina · Dikemas kini 22 Sep 2026 · NCT07483073A Master Protocol (AMAZ): A Study of Mirikizumab (LY3074828) in Pediatric Participants With Ulcerative Colitis or Crohn's Disease (SHINE-ON)
Mengambil pesertaFasa 3
Umur 2 hingga 19 · Semua jantina · Dikemas kini 22 Sep 2026 · NCT04844606A Study of LY4395089 and Mirikizumab (LY3074828) Given Together and Mirikizumab (Alone) in Adults With Crohn's Disease
Mengambil pesertaFasa 2
Umur 18 hingga 80 · Semua jantina · Dikemas kini 22 Sep 2026 · NCT07483099A Study of Vedolizumab Intravenous (IV) and Adalimumab or Vedolizumab and Ustekinumab in Adults With Crohn's Disease
Mengambil pesertaFasa 4
Umur 18 hingga 70 · Semua jantina · Dikemas kini 9 Sep 2026 · NCT06045754Daripada ClinicalTrials.gov, data diperoleh pada 4 Okt 2026. Setiap kajian menetapkan kriteria kelayakannya sendiri; pasukan kajian menentukan siapa yang layak menyertai.